- 2021 Investment results
7 exits, 11 new private companies and a record year for the pre-IPO market amid new COVID-19 variants, rising inflation and stock market uncertainty.
- Conversion of Ginkgo Bioworks shares
In September, Biotech went public through a merger agreement with SPAC. Ginkgo shares were converted into the shares of a new public company – the number of shares increased by 49.08 times, and their price decreased by 49.08 times.
- Changes to pre-IPO futures expiration dates
We have moved the expiration date of futures contracts in the event of a company’s IPO or direct listing to the 200th day of the offering.